Incident hypertension and hypertension-related outcomes can be predicted by an artificial intelligence-enhanced electrocardiography (AI-ECG) model, AI-ECG risk estimator to predict incident hypertension, results from a cohort study show.
Redo transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 (S3) valve presents challenges, according to a new analysis of patient data that also shows downsizing is frequent, and under-expansion may lead to suboptimal hemodynamics.
New study findings challenge established practices in transcatheter aortic valve replacement (TAVR), as researchers demonstrate that transradial secondary access (TR-SA) significantly reduces complications compared to traditional transfemoral secondary access (TF-SA).
A first-in-human study has demonstrated the exceptional safety and efficacy of the Magenta Elevate mechanical circulatory support (MCS) device during high-risk percutaneous coronary interventions (HR-PCI) involving the left main coronary artery (LM).
Angiography-based physiological assessments can offer additional prognostic insights for patients undergoing intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI), according to a post-hoc analysis of the FLAVOUR trial.
A new machine learning assessment of the ECLS-SHOCK study found there is a “low likelihood” that any subpopulation of infarct-related cardiogenic shock (CS) patients will respond to extracorporeal life support (ECLS).
Cardiac rhythm monitoring after stroke continues to be a topic of debate as improved monitoring strategies increase likelihood of arrhythmia detection post-stroke, but impacts on secondary stroke prevention are still unclear, reports an expert consensus.
Hypertension and obesity are the strongest risk factors for new-onset heart failure (HF) in both men and women, but women are still at greater risk than men, a new analysis shows.
Should Sex be a Factor in Deciding 3VD Patients’ Revascularization Strategy?
Potential Risk Factors for Progressive Ascending Aorta Dilation in BAV Patients Undergoing TAVR Identified: Exploratory Analysis
Bailey G. Salimes, CRTonline.org
Natalie Morrison, CRTonline.org
Nathan Gray, CRTonline.org
Will Chu, CRTonline.org
Michael Mahmoudi, MD - K Goel, et al.; Circulation 2024; 150:1493-1504
Michael Mahmoudi, MD - N Singh, et al.; JACC Cardiovasc Interv 2024; 17:2337-2349
Michael Mahmoudi, MD - P Ridker, et al.; NEJM 2024; 391:2087-2097
Michael Mahmoudi, MD - R Hahn, et al. NEJM 2024 Online
EINPresswire
Recor
BUSINESS WIRE
Which of the following trials presented in 2024 will have the greatest impact on your practice?
DANGER SHOCK
TRISCEND II TRIAL
ECLIPSE
CLEAR SYNERGY OASIS 9
EARLY TAVR
SMART
RESHAPE-HF2 Trial
PREVENT
ORBITA-COSMIC
Shumail Fatima, Matthew E. Harinstein, Mubashir Hussain and John J. Pacella
Jay Khambhati, Piotr Sobieszczyk, Andrew C. Eisenhauer, Thomas M. Todoran and Scott Kinlay
Yusuke Uemura, Akihito Tanaka, Yuta Ozaki, Shogo Yamaguchi, Takashi Okajima, Takayuki Mitsuda, Shinji Ishikawa, Kenji Takemoto, Toyoaki Murohara and Masato Watarai
Carlos Diaz-Arocutipa, Cesar Joel Benites-Moya, Samuel J. Apple and Saraschandra Vallabhajosyula
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details